Cryptic Terran Licences Advanced CNS Assets From Sanofi

Deal Value Under Wraps

 
• By Ayisha Sharma

The US biotech has nabbed a couple of Sanofi’s Phase III CNS candidates, its third deal of the year aimed at transforming the neuropsychiatry market. 

Terran Has Kept The Details Of Its Pipeline Under Lock And Key • Source: Alamy

More from Deals

More from Business